MedRx Co. Ltd. reported consolidated earnings results for the six months ended June 30, 2019. For the six months, the company reported net sales of JPY 28 million compared to JPY 8 million a year ago. Operating loss was JPY 877 million compared to JPY 575 million a year ago. Ordinary loss was JPY 884 million compared to JPY 588 million a year ago. Loss attributable to owners of parent was JPY 867 million or JPY 77.14 per share compared to JPY 572 million or JPY 58.44 per share a year ago.

For the year ending December 31, 2019, the company forecasts consolidated net sales of JPY 1,009 million, operating loss of JPY 949 million, ordinary loss of JPY 955 million and loss attributable to owners of parent of JPY 943 million or JPY 74.18 per share.